Mirador Therapeutics, Inc.
5 clinical trials · Sponsor
◉ Watch Mirador Therapeutics, Inc.
| Record | Firm | Date |
|---|---|---|
| A First-in-Human Single and Multiple Ascending Dose Study of MT-701 (NCT07396909) | Mirador Therapeutics, Inc. | 2026-01-12 |
| A First-in-Human Single and Multiple Ascending Dose Study of MT-201 (NCT07219368) | Mirador Therapeutics, Inc. | 2025-10-08 |
| A Phase 2 Study to Evaluate Therapies for Inflammatory Bowel Disease (NCT07113522) | Mirador Therapeutics, Inc. | 2025-06-26 |
| A First-in-Human Single and Multiple Ascending Dose Study of MT-501 (NCT06762457) | Mirador Therapeutics, Inc. | 2024-12-11 |
Track Mirador Therapeutics, Inc. automatically
Every clearance here is in the API, with alerts when new ones post.